EKF Diagnostics (LON:EKF) Stock Price Down 7% - Time to Sell?

Key Points

• EKF Diagnostics' stock dropped 7% during trading, closing at GBX 26 ($0.35) after a significant increase in trading volume, up 404% from its average daily volume.
• The company has a market cap of £116.76 million and reported a quarterly net margin of 9.37% with an EPS of GBX 0.43.
• Analysts project EKF Diagnostics will achieve a full-year EPS of approximately 2.30 for the current year, reflecting expectations for the company's financial performance.

EKF Diagnostics Holdings plc (LON:EKF - Get Free Report) traded down 7% during mid-day trading on Saturday . The company traded as low as GBX 23.60 ($0.31) and last traded at GBX 26 ($0.35). 2,281,890 shares were traded during trading, an increase of 404% from the average session volume of 453,091 shares. The stock had previously closed at GBX 27.95 ($0.37).

EKF Diagnostics Price Performance

The stock has a market capitalization of £116.76 million, a P/E ratio of 19.26 and a beta of 0.57. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.77 and a current ratio of 4.60. The firm has a 50-day moving average price of GBX 29.18 and a 200 day moving average price of GBX 26.59.

EKF Diagnostics (LON:EKF - Get Free Report) last issued its earnings results on Tuesday, September 16th. The company reported GBX 0.43 earnings per share (EPS) for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. On average, analysts expect that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current year.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.